Specialty Pharmacy Audit Defense · LDDs · REMS · Oncology · Biologics · High-Cost Claims

Specialty Pharmacy Audit Defense Attorneys

Defense for specialty pharmacies facing PBM and manufacturer audits of LDD, REMS, oncology, and biologic claims.

Request a Free Case Review
Audit Hotline - Direct Line
(800) 345 - 4125
Speak with an attorney - not a call center. Immediate response.
Specialty Pharmacy Audit Defense Briefing

PBM Audits and Defense Scope

Specialty pharmacy claims represent a disproportionate share of every PBM's audit selection. Limited distribution drugs (LDDs), REMS-restricted programs (Risk Evaluation and Mitigation Strategies), oncology dispensing, biologics, and high-cost specialty drugs all carry concentrated audit risk.

Auditors review each NDC against tier placement and manufacturer protocol, and pharmacies that dispense to 340B covered entities face an additional parallel review track.

A single flagged claim can trigger six- and seven-figure recoupments, network termination, and parallel manufacturer LDD network exclusions that cut off the pharmacy's access to the underlying drug. Health Law Alliance defends specialty pharmacies before the audit closes. The defense framework starts with the LDD agreement and the REMS protocol.

Federal regulators are increasingly delegating Medicaid enforcement to the states. State Medicaid Fraud Control Units and state Attorneys General are now the primary enforcement vector for pharmacy Medicaid claims - and have grown significantly more aggressive since 2023. The defense framework starts with the state regulatory regime.

2,500+
Clients Represented
96%
Reduction of a $4.7M OptumRx Demand
2,000+
Audits Overseen by Our Bench
Immediate
Response - Audit Notices Don't Wait
Client Reviews
What Clients Say
5.0
"By the time the audit letter arrives, you have 30 days. The pharmacies that win are the ones that mobilize in the first 72 hours."
Protect Your Pharmacy Now →
Illustrative stack of legal and medical records prepared for document review
Document review · Illustrative image, not a client record
Document Review

The audit response shapes the findings and the appeal

A PBM audit runs on the deadlines in your network agreement. What you produce, and when, becomes the record the PBM uses to set findings, chargebacks, and any network action.

Notice and contract deadlineIdentify the audit type and the appeal windows the network agreement imposes.
Audit type and auditorConfirm whether the matter is a desk audit, an onsite audit, or an investigational audit, and which PBM or delegate is running it.
Claims and documentation at issueReview the claim sample and the requested records before producing a file that cannot be withdrawn.
The HLA Defense Process
A four-stage defense protocol

Our bench includes a former federal prosecutor who served as Chief Compliance Officer of UnitedHealth Group, OptumRx’s parent company.

  • Notice triage & deadline lock
  • Chart-level defense build
  • Level-1 & Level-2 appeal response
  • Litigation & regulatory containment
Conference room
Where defense is built
01
Notice triage & deadline lock

Within 24 hours: parse every deadline in the audit notice, place a litigation hold on the claims at issue, and preserve adjudication logs before the PBM rotates them out.

02
Chart-level defense build

Claim-by-claim reconstruction: prescriber PA rationale, plan criteria at time of fill, BMI/A1C/comorbidity support, step-therapy chain, and compounding regulatory posture. Every flagged script gets its own defense memo.

03
Level-1 & Level-2 appeal response

We draft and file the written appeal, quantify the PBM's extrapolation errors, and negotiate directly with the auditor and network relations.

04
Litigation & regulatory containment

If the PBM refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, FDA, and the state board - so a PBM dispute does not escalate into a license action.

Health Law Alliance attorneys
The HLA Bench

The HLA Specialty Pharmacy Audit Defense Team

Health Law Alliance handles the response and any parallel appeal, licensing matter or referral as one coordinated matter, so the strategy does not change hands as the matter moves between forums.

The bench includes a former Assistant U.S. Attorney nominated for the DOJ Director's Award, senior healthcare-company counsel, and attorney-providers with experience across healthcare audits and investigations.

Health Law Alliance

Firm record

5,000+Matters handled
2,500+Clients represented
2,000+Audits overseen
ImmediateAttorney response
Former professional experience

Where Our Attorneys Served Before Health Law Alliance

Department of Justice Former Assistant U.S. Attorney
Drug Enforcement Administration Former DEA Diversion Program Manager
UnitedHealth Group Former Chief Compliance Officer
McKesson Former Chief Counsel and Vice President

Agency and company marks identify former professional experience of individual HLA team members. They do not imply affiliation, endorsement, or a client relationship.

Speak with an Attorney Today

Get a free, privileged review of your matter before you respond

Before you write a single page of your written response, have a privileged conversation with attorneys who have overseen 2,000+ audits - from both sides of the table. Free, confidential, no retainer.

Under audit? Speak with an attorney today.